Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour stomach is unsettled, there's a bottle of Pepto-Bismol in the bathroom cabinet, and you're on Mounjaro. Whether that combination is safe is a completely fair question — and the short answer is that there is no documented pharmacokinetic interaction between bismuth subsalicylate (the active ingredient in Pepto-Bismol) and tirzepatide, but there are reasons to think carefully before reaching for it. These are prescription-only medicines requiring clinical assessment, and any decision about adding over-the-counter products should involve your prescriber or pharmacist. The sections below give you the facts so that conversation can start from the right place.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the situation a lot of people find themselves in, especially in the first few weeks or after a dose step-up. Mounjaro works partly by slowing the rate at which food leaves your stomach — a mechanism that reduces appetite but can also trigger nausea, indigestion, or loose stools, particularly if you've eaten a large or fatty meal. The discomfort is real, and it makes sense that you'd scan the medicine cabinet for relief.
Pepto-Bismol's main job is to coat the stomach lining, reduce irritation, and slow intestinal movement. For ordinary stomach upsets it works well. On Mounjaro, though, the picture is slightly more complicated, and if you want the full detail on how the two interact, our Pepto-Bismol and Mounjaro page covers it thoroughly. Tirzepatide is already slowing gastric emptying; adding bismuth subsalicylate slows transit further. If constipation is part of what's bothering you, Pepto-Bismol could make it worse rather than better. It's worth checking the label to confirm which symptom the product is actually targeting before you open it, a one-minute habit that catches a lot of avoidable mistakes.
There's also the absorption question. Because Mounjaro delays how quickly the stomach empties, oral medicines taken alongside it can behave differently, their absorption may be slower or more variable. This doesn't mean Pepto-Bismol is harmful, but it does mean the timing of other oral medicines you take matters. The NHS tirzepatide medicines page notes this interaction potential explicitly, and it's the starting point for any query about combining tirzepatide with other oral products.
Mounjaro's dual GIP and GLP-1 receptor agonism makes it distinctive among weight-loss medicines; that same mechanism is why its effect on the gut is stronger than some people expect. Gastric emptying slows noticeably, especially at higher doses. For oral contraceptives, this is significant enough that the prescribing guidance for tirzepatide recommends adding a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, precisely because pill absorption can be reduced.
Pepto-Bismol is not in the same category of clinical concern, but the principle is the same: the stomach is working at a different pace than usual, and that changes the environment for everything you put in it. If you're using Pepto-Bismol to manage nausea specifically, it's worth knowing that antiemetics work through different pathways and your prescriber may consider one of those more appropriate for GLP-1-related nausea. Staying well-hydrated and eating smaller, lower-fat meals is often the first-line advice for GI symptoms on Mounjaro, simple, but genuinely effective for many people.
You can read more about how tirzepatide works as a molecule on the tirzepatide overview page, which covers the dual-receptor mechanism in fuller detail. Part of what makes tirzepatide's mechanism distinctive is its molecular identity, and if you've ever wondered whether Mounjaro is classed as a peptide, we explain exactly how it's categorised and why that matters.
Most GI discomfort on Mounjaro is mild and short-lived. But some symptoms need medical attention rather than a cabinet remedy. Severe stomach pain (especially pain that radiates through to your back, with or without vomiting) requires urgent assessment because it can be a sign of pancreatitis, a known though infrequent side effect of GLP-1 medicines. The MHRA issued a specific safety communication on this in early 2026. Signs of significant dehydration from persistent vomiting or diarrhoea also warrant a call to your GP or 111, not a dose of Pepto-Bismol.
If your stomach symptoms are severe, repeated, or getting worse rather than better, the right move is to contact your prescriber. At nume, aftercare is available seven days a week, so if something doesn't feel right, that conversation doesn't have to wait until Monday morning. You can reach the team via the contact page.
For a broader look at what Mounjaro treatment involves (eligibility, what happens at each stage, and what the evidence shows) the Mounjaro treatment page covers all of it. And if you're curious about where Mounjaro sits in the wider category of treatments, the FAQs page addresses common queries about how the service works, including questions about the peptide name behind Mounjaro for those who like to understand the science. Pricing context, for those weighing up private options, is set out honestly on the Mounjaro prices page.
If you're not yet on treatment and would like a prescriber to assess your suitability, the team at nume reviews consultations the same day a real clinician, not a screening tool, reads your answers. Speak to our prescribers to get started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.